These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1312395)

  • 1. Calf thymus DNA binding/bonding properties of CC-1065 and analogs as related to their biological activities and toxicities.
    Krueger WC; Prairie MD
    Chem Biol Interact; 1992 Mar; 82(1):31-46. PubMed ID: 1312395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin of the DNA induced circular dichroism of CC-1065 and analogs.
    Krueger WC; Prairie MD
    Chem Biol Interact; 1991; 79(2):137-49. PubMed ID: 1884427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA.
    Sun D; Hurley LH
    Anticancer Drug Des; 1992 Feb; 7(1):15-36. PubMed ID: 1543525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of interaction of CC-1065 (NSC 298223) with DNA.
    Swenson DH; Li LH; Hurley LH; Rokem JS; Petzold GL; Dayton BD; Wallace TL; Lin AH; Krueger WC
    Cancer Res; 1982 Jul; 42(7):2821-8. PubMed ID: 7083173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence recognition by the antitumor antibiotic CC-1065 and analogs of CC-1065.
    Krueger WC; Hatzenbuhler NT; Prairie MD; Shea MH
    Chem Biol Interact; 1991; 79(3):265-86. PubMed ID: 1913973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of the antitumor antibiotic CC-1065 and its analogues in mammalian (V79) cells and bacteria.
    Harbach PR; Zimmer DM; Mazurek JH; Bhuyan BK
    Cancer Res; 1988 Jan; 48(1):32-6. PubMed ID: 3334998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065.
    Park HJ
    Arch Pharm Res; 2002 Feb; 25(1):11-24. PubMed ID: 11885687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A noncovalent binding-translocation mechanism for site-specific CC-1065-DNA recognition.
    Gunz D; Naegeli H
    Biochem Pharmacol; 1996 Aug; 52(3):447-53. PubMed ID: 8687499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of CC-1065 and its analogues with mouse DNA and chromatin.
    Moy BC; Prairie MD; Krueger WC; Bhuyan BK
    Cancer Res; 1989 Apr; 49(8):1983-8. PubMed ID: 2702639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA.
    Hurley LH; Sun D
    J Mol Recognit; 1994 Jun; 7(2):123-32. PubMed ID: 7826672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA.
    Sun D; Hurley LH
    J Med Chem; 1992 May; 35(10):1773-82. PubMed ID: 1588557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex.
    Needham-VanDevanter DR; Hurley LH; Reynolds VL; Theriault NY; Krueger WC; Wierenga W
    Nucleic Acids Res; 1984 Aug; 12(15):6159-68. PubMed ID: 6473105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting.
    Ding ZM; Harshey RM; Hurley LH
    Nucleic Acids Res; 1993 Sep; 21(18):4281-7. PubMed ID: 8414983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of the covalent reaction of CC-1065 and analogues with DNA.
    Warpehoski MA; Harper DE; Mitchell MA; Monroe TJ
    Biochemistry; 1992 Mar; 31(9):2502-8. PubMed ID: 1547233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The minor groove covalent reactive drugs anthramycin and (+)-CC-1065 and their interstrand cross-linking derivatives.
    Hurley LH
    IARC Sci Publ; 1994; (125):295-312. PubMed ID: 7806319
    [No Abstract]   [Full Text] [Related]  

  • 18. CC-1065 bonding to intracellular and purified SV40 DNA: site specificity and functional effects.
    McHugh MM; Woynarowski JM; Mitchell MA; Gawron LS; Weiland KL; Beerman TA
    Biochemistry; 1994 Aug; 33(31):9158-68. PubMed ID: 8049219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity.
    Reynolds VL; Molineux IJ; Kaplan DJ; Swenson DH; Hurley LH
    Biochemistry; 1985 Oct; 24(22):6228-37. PubMed ID: 3002434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA.
    Lee CS; Sun D; Kizu R; Hurley LH
    Chem Res Toxicol; 1991; 4(2):203-13. PubMed ID: 1782349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.